Clinical Registries Need Streamlining To Reap Benefits, Mussallem Tells Congress

Clinical registries can yield useful information on patient outcomes that can support approval, reimbursement and care decisions but the benefits of registries need to be balanced against their costs, Edwards Lifesciences CEO Michael Mussalem told a House Energy and Commerce subcommittee July 22.

Edwards Lifesciences CEO Michael Mussallem testified

that clinical registries are one way to overcome barriers to clinical evidence development at a July 22 House subcommittee meeting on the barriers, but warned the benefits of registries...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D